Chemotherapy Naive Prostate Cancer
1 clinical trials · Condition
◉ Watch Chemotherapy Naive Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer (NCT01313559) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-06-01 |
Track Chemotherapy Naive Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.